These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38035442)

  • 1. Reply to Letter to the Editor regarding Anudjo et al. 'Considerations for environmental sustainability in clinical radiology and radiotherapy practice: A systematic literature review and recommendations for a greener practice'.
    Anudjo MNK; Vitale C; Elshami W; Hancock A; Adeleke S; Franklin JM; Akudjedu TN
    Radiography (Lond); 2024 Jan; 30(1):257. PubMed ID: 38035442
    [No Abstract]   [Full Text] [Related]  

  • 2. Re Anudjo et al. 'Considerations for environmental sustainability in clinical radiology and radiotherapy practice: A systematic literature review and recommendations for a greener practice'.
    Soares AL; Couto JG; Bravo I; Buttigieg SC; McFadden S
    Radiography (Lond); 2024 Jan; 30(1):176-177. PubMed ID: 38035430
    [No Abstract]   [Full Text] [Related]  

  • 3. Considerations for environmental sustainability in clinical radiology and radiotherapy practice: A systematic literature review and recommendations for a greener practice.
    Anudjo MNK; Vitale C; Elshami W; Hancock A; Adeleke S; Franklin JM; Akudjedu TN
    Radiography (Lond); 2023 Oct; 29(6):1077-1092. PubMed ID: 37757675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.
    Cherny NI; Sullivan R; Dafni U; Kerst JM; Sobrero A; Zielinski C; de Vries EGE; Piccart MJ
    Ann Oncol; 2016 Jan; 27(1):205-207. PubMed ID: 32645815
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.
    Cherny NI; Sullivan R; Dafni U; Kerst JM; Sobrero A; Zielinski C; de Vries EG; Piccart MJ
    Ann Oncol; 2016 Jan; 27(1):203-5. PubMed ID: 26519490
    [No Abstract]   [Full Text] [Related]  

  • 6. Concerns with conclusions in the article by Sherwood
    Karlin-Neumann G
    ESMO Open; 2018; 3(1):e000287. PubMed ID: 29345689
    [No Abstract]   [Full Text] [Related]  

  • 7. Author's Reply to the "Letter to the Editor Regarding 'The Performance of Opioid-Free Anesthesia for Bariatric Surgery in Clinical Practice'".
    Ulbing S; Infanger L; Fleischmann E; Prager G; Hamp T
    Obes Surg; 2024 Mar; 34(3):1020-1021. PubMed ID: 37752325
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustainable radiology departments: A European survey to explore radiographers' perceptions of environmental and energy sustainability issues.
    Roletto A; Catania D; Rainford L; Savio A; Zanardo M; Bonfitto GR; Zanoni S
    Radiography (Lond); 2024 Jun; 30 Suppl 1():81-90. PubMed ID: 38996669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Petrelli F; Solinas C
    Thromb Res; 2021 Dec; 208():217-218. PubMed ID: 33810866
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the editor: Reply to Ali et al.
    Kim MS; Wilke DR
    Clin Transl Radiat Oncol; 2024 May; 46():100776. PubMed ID: 38654940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to "Letter to the editor of Pfister et al" regarding "The scarcity-weighted water footprint provides unreliable water sustainability scoring".
    Vanham D; Mekonnen MM
    Sci Total Environ; 2022 Jun; 825():154750. PubMed ID: 35396131
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Sato et al. Letter to the Editor: Diagnosis and treatment of Wernicke's encephalopathy: A systematic literature review.
    Cantu-Weinstein A; Weleff J; Nero N; Anand A
    Gen Hosp Psychiatry; 2024; 90():189-190. PubMed ID: 38852009
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
    Willame C; Lin L; Vetter V; Baril L; Praet N
    Vaccine; 2018 Oct; 36(45):6589-6590. PubMed ID: 30348362
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to the Letter to the Editor "Considerations for incorporating circulating miRNA into reproductive medicine-A letter regarding Naeimi et al. study".
    Naeemi N; Mahmoudzadeh-Sagheb H; Heidari Z
    Int J Urol; 2024 Jul; 31(7):836. PubMed ID: 38864589
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to the Letter to the editor in response to the Position statement and best practice recommendations on the imaging use of ultrasound from the European Society of Radiology ultrasound subcommittee.
    Brady AP; Clevert DA; Sidhu PS;
    Insights Imaging; 2021 May; 12(1):62. PubMed ID: 34018060
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9) and the reply to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9).
    Edwards KL
    Eur Spine J; 2018 Nov; 27(11):2889-2890. PubMed ID: 30327911
    [No Abstract]   [Full Text] [Related]  

  • 17. In reply to letter to the editor by Dr Willems et al. re: Eccles et al. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations.
    Eccles C; Haider MA; Dawson LA
    Acta Oncol; 2010; 49(2):256-7. PubMed ID: 20017663
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65: Salvage Radiotherapy and Hormone Therapy: Change Is Coming, Just Not Quite Yet.
    Spratt DE; Dess RT; Feng FY
    Eur Urol; 2018 Mar; 73(3):e64-e65. PubMed ID: 29111144
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to letter to the editor by J.-M. Kim et al. on "Sexual function and quality of life in women with cervical cancer before radiotherapy: a pilot study" by Grion et al.
    Grion RC; Baccaro LF; Vaz AF; Costa-Paiva L; Conde DM; Pinto-Neto AM
    Arch Gynecol Obstet; 2016 Jul; 294(1):211. PubMed ID: 27052444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.